Cargando…

Warfarin pharmacogenetics: How close are we to clinical practice?

Detalles Bibliográficos
Autores principales:	Gaikwad, Tejasvita, Shetty, Shrimati, Ghosh, Kanjaksha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841549/ https://www.ncbi.nlm.nih.gov/pubmed/24339537 http://dx.doi.org/10.4103/0971-6866.120806

Ejemplares similares

Possible impact of factor V Leiden genotype on warfarin induced bleeding
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

Falciparum malaria selected while HIV-1 slaughtered
por: Ghosh, Kanjaksha, et al.
Publicado: (2008)

Genetic Heterogeneity in a Large Cohort of Indian Type 3 von Willebrand Disease Patients
por: Kasatkar, Priyanka, et al.
Publicado: (2014)

Additional markers for genetic diagnosis of type 3 von Willebrand disease in Indian population
por: Kasatkar, Priyanka, et al.
Publicado: (2015)

Nanoimaging in cardiovascular diseases: Current state of the art
por: Deb, Suryyani, et al.
Publicado: (2015)

Elevated Procoagulant Endothelial and Tissue Factor Expressing Microparticles in Women with Recurrent Pregnancy Loss
por: Patil, Rucha, et al.
Publicado: (2013)

Mutations in Intron 1 and Intron 22 Inversion Negative Haemophilia A Patients from Western India
por: Nair, Preethi S., et al.
Publicado: (2014)

High heterozygosity frequency of three exonic SNPs of factor V gene (F5): implications for genetic diagnosis
por: Jadli, Anshul, et al.
Publicado: (2015)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

A possible need for routine screening for Strongyloides stercoralis infection in Indian haemophilia patients
por: Patil, Rucha K., et al.
Publicado: (2018)

Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
por: Di Maso, Vittorio, et al.
Publicado: (2014)

Systematic Review of Pharmacogenetic Warfarin Dosing
por: van Schie, Rianne M. F., et al.
Publicado: (2009)

Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India
por: Vora, Sonal, et al.
Publicado: (2007)

Novel Deleterious Sequence Change in the NLRP12 Gene in a Child with the Autoinflammatory Syndrome, Joint Hypermobility and Cutis Laxa from India
por: Ghosh, Kanjaksha, et al.
Publicado: (2019)

Bombay phenotype in Orissa: What could we make out of it?
por: Ghosh, Kanjaksha, et al.
Publicado: (2007)

Liquid Biopsy in Gastrointestinal Cancers: How Close Are We to Reaching the Clinic?
por: Earl, Julie, et al.
Publicado: (2023)

Warfarin Dosage Response Related Pharmacogenetics in Chinese Population
por: Li, Siyue, et al.
Publicado: (2015)

Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database
por: Liu, Rong, et al.
Publicado: (2015)

Omics in Clinical Practice: How Far Are We?
por: Sáez, María Eugenia
Publicado: (2022)

The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort
por: Al Ammari, Maha, et al.
Publicado: (2020)

Association Studies in Clinical Pharmacogenetics
por: Zubiaur, Pablo, et al.
Publicado: (2022)

Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?
por: Palmirotta, Raffaele
Publicado: (2021)

Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients
por: Galvez, Jubby Marcela, et al.
Publicado: (2018)

Clinical Application of Pharmacogenetics: Where are We Now?
por: van Schaik, Ron HN
Publicado: (2014)

How We Can Change Clinical Practice Using Antioxidant Molecules?
por: Favero, Gaia, et al.
Publicado: (2022)

Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?
por: Luzum, Jasmine A., et al.
Publicado: (2016)

Warfarin Anticoagulant Therapy: A Southern Italy Pharmacogenetics-Based Dosing Model
por: Mazzaccara, Cristina, et al.
Publicado: (2013)

Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin
por: Kangelaris, Kirsten Neudoerffer, et al.
Publicado: (2009)

Establishment of a Han Chinese-specific pharmacogenetic-guided warfarin dosing algorithm
por: Pei, Lin, et al.
Publicado: (2018)

Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina
por: Ašić, Adna, et al.
Publicado: (2019)

Clinical Islet Xenotransplantation: How Close Are We?
por: van der Windt, Dirk J., et al.
Publicado: (2012)

Familial Mediterranean fever: An unusual disease enlightening the inflammation biology
por: Ghosh, Kanjaksha
Publicado: (2014)

Annoucement
por: Ghosh, Kanjaksha
Publicado: (2012)

Molecular Pathology of Rare Bleeding Disorders (RBDs) in India: A Systematic Review
por: Kulkarni, Bipin P., et al.
Publicado: (2014)

A Pharmacogenetics-Based Warfarin Maintenance Dosing Algorithm from Northern Chinese Patients
por: Chen, Jinxing, et al.
Publicado: (2014)

A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics
por: Duconge, Jorge, et al.
Publicado: (2016)

Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds
por: Chang, Grace Shu-wen, et al.
Publicado: (2020)

Pharmacogenetic-Guided Algorithm to Improve Daily Dose of Warfarin in Elder Han-Chinese Population
por: Ren, Yirong, et al.
Publicado: (2020)

Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
por: Roche-Lima, Abiel, et al.
Publicado: (2020)

Knee Osteoarthritis—How Close Are We to Disease-Modifying Treatment: Emphasis on Metabolic Type Knee Osteoarthritis
por: Lambova, Sevdalina Nikolova
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f310vjl5k2lkscq2ij2hr8o8qa